Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios
- DOI
- 10.1002/dad2.12314
- Published
- 2022-01
- Container
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/dad2.12314,
title = {Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios},
author = {Femke H. Bouwman and Giovanni B. Frisoni and Sterling C. Johnson and Xiaochun Chen and Sebastiaan Engelborghs and Takeshi Ikeuchi and Claire Paquet and Craig Ritchie and Sasha Bozeat and Frances‐Catherine Quevenco and Charlotte Teunissen},
year = {2022},
journal = {Alzheimer's \& Dementia: Diagnosis, Assessment \& Disease Monitoring},
doi = {10.1002/dad2.12314},
url = {https://doi.org/10.1002/dad2.12314}
}RIS
TY - JOUR TI - Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios AU - Femke H. Bouwman AU - Giovanni B. Frisoni AU - Sterling C. Johnson AU - Xiaochun Chen AU - Sebastiaan Engelborghs AU - Takeshi Ikeuchi AU - Claire Paquet AU - Craig Ritchie AU - Sasha Bozeat AU - Frances‐Catherine Quevenco AU - Charlotte Teunissen PY - 2022 JO - Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring DO - 10.1002/dad2.12314 UR - https://doi.org/10.1002/dad2.12314 ER -
APA
Bouwman, F. H., Frisoni, G. B., Johnson, S. C., Chen, X., Engelborghs, S., Ikeuchi, T., Paquet, C., Ritchie, C., Bozeat, S., Quevenco, F., & Teunissen, C. (2022). Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. https://doi.org/10.1002/dad2.12314
Source records
- crossref · retrieved 2026-09-27T14:59:24.765Z